/term/debt-to-asset/XCNQ:WESA.X Wesana Health Holdings (XCNQ:WESA.X) Debt-to-Asset
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wesana Health Holdings Inc (XCNQ:WESA.X) » Definitions » Debt-to-Asset

Wesana Health Holdings (XCNQ:WESA.X) Debt-to-Asset : 0.34 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Wesana Health Holdings Debt-to-Asset?

Wesana Health Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$0.34 Mil. Wesana Health Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$0.00 Mil. Wesana Health Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was C$1.00 Mil. Wesana Health Holdings's debt to asset for the quarter that ended in Mar. 2024 was 0.34.


Wesana Health Holdings Debt-to-Asset Historical Data

The historical data trend for Wesana Health Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wesana Health Holdings Debt-to-Asset Chart

Wesana Health Holdings Annual Data
Trend Apr20 Apr21 Dec22 Dec23
Debt-to-Asset
- - 0.15 0.25

Wesana Health Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 - 0.15 0.25 0.34

Competitive Comparison of Wesana Health Holdings's Debt-to-Asset

For the Biotechnology subindustry, Wesana Health Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wesana Health Holdings's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wesana Health Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Wesana Health Holdings's Debt-to-Asset falls into.



Wesana Health Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Wesana Health Holdings's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Wesana Health Holdings's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wesana Health Holdings  (XCNQ:WESA.X) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Wesana Health Holdings Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Wesana Health Holdings's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Wesana Health Holdings (XCNQ:WESA.X) Business Description

Traded in Other Exchanges
Address
745 Thurlow Street, Suite 2400, Vancouver, BC, CAN, V6E 0C5
Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. The Company is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma with the help of extensive clinical research and academic partnerships.

Wesana Health Holdings (XCNQ:WESA.X) Headlines

No Headlines